EGFR-IN-8 |
Catalog No.GC39568 |
L'EGFR-IN-8 est un double inhibiteur de l'EGFR et de la c-Met, le composé 48. L'EGFR-IN-8 peut être un candidat prometteur pour un développement ultérieur visant À cibler le NSCLC résistant À l'EGFR TKI.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2407957-87-1
Sample solution is provided at 25 µL, 10mM.
EGFR-IN-8 is a dual EGFR and c-Met inhibitor, compound 48. EGFR-IN-8 can be a promising candidate for further development to target EGFR TKI-resistant NSCLC[1].
[1]. Dokla EME, et al. 1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC. Eur J Med Chem. 2019 Aug 9;182:111607.
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *